117 results
Page 4 of 6
8-K
dltmv21crbtb 10h5
11 Jan 21
Syros Announces Strategic Priorities and Expected Milestones
7:53am
8-K
EX-99.1
bls8n8qc5 7679hq
11 Jan 21
Syros Announces Strategic Priorities and Expected Milestones
7:53am
8-K
EX-99.1
sy2 cs3ah2zm
8 Dec 20
Syros Closes $90.5 Million Strategic Financing
4:44pm
8-K
38zza
7 Dec 20
Entry into a Material Definitive Agreement
6:05am
8-K
EX-99.3
wz317dcs2r
7 Dec 20
Entry into a Material Definitive Agreement
6:05am
8-K
EX-99.1
u7o0z06e
7 Dec 20
Entry into a Material Definitive Agreement
6:05am
8-K
EX-2.1
pl9 oab07g6b
7 Dec 20
Entry into a Material Definitive Agreement
6:05am
8-K
EX-10.1
pozax9 e5
7 Dec 20
Entry into a Material Definitive Agreement
6:05am
8-K
EX-99.2
2417ojcvv fc15
7 Dec 20
Entry into a Material Definitive Agreement
6:05am
8-K
56myptxeh6lwahbfo
26 Oct 20
Syros Presents Initial Data from Phase 1 Clinical Trial of SY-5609, Its Selective Oral
6:10am
8-K
EX-99.1
its9c78
26 Oct 20
Syros Presents Initial Data from Phase 1 Clinical Trial of SY-5609, Its Selective Oral
6:10am
8-K
EX-99.1
i3ipmhv kz
13 Feb 20
Syros Announces $60 Million Loan Facility with Oxford Finance LLC
8:51am
8-K
EX-99.2
9uya3ag
13 Jan 20
Regulation FD Disclosure
6:11am
8-K
EX-99.1
ib5wbu
13 Jan 20
Regulation FD Disclosure
6:11am